Adverse drug reaction reporting in Australian hospitals

International Journal of Pharmacy Practice

Volumn 12, Issue 3, 2004, Pages 155-161

  Nita, Yunita ^a   Plumridge, Richard J ^b   Batty, Kevin T ^a  

^a CURTIN UNIVERSITY   (Australia)

^b Pharmaceutical Healthcare ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; DOCUMENTATION; DRUG SURVEILLANCE PROGRAM; FEEDBACK SYSTEM; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE POLICY; HOSPITAL DISCHARGE; HOSPITAL PHARMACY; PHARMACIST; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 4644294411     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357044030     Document Type: Article

References (28)

1. Stephens MD, Talbot JC, Routledge PA. Detection of new adverse drug reactions. London: MacMillan; 1998.
2. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ 1998;316:1295-8.
3. Lee A, Rawlins MD. Adverse drug reaction. In: Walker R, Edwards C, editors. Clinical pharmacy and therapeutics. Edinburgh: Churchill Livingstone; 1999. pp33-45.
4. Roughead EE. The nature and extent of drug-related hospitalisations in Australia. J Qual Clin Pract 1999;19:19-22.
5. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed. J R Coll Physicians Lond 1995;29:41-9.
6. Belton KJ, Lewis SC, Payne S, Rawlins MD, Wood SM. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br J Clin Pharmacol 1995;39:223-6.
7. Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Martin Arias LH. Under-reporting of adverse drug reactions. Eur J Clin Pharmacol 1998;54:483-8.
8. Pillans PI, Mathew TH, Coulter DM. Pharmacovigilance in Australia and New Zealand: towards 2000. Med J Aust 1999;170:245-6.
9. Rohan A. Adverse drug reactions - they are all important. Aust J Hosp Pharm 1992;22:166-7.
10. Eland IA, Belton KJ, Van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol 1999;48:623-7.
11. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur J Clin Pharmacol 1997;52:423-7.
12. Green CF, Mottram DR, Rowe PH, Pirmohamed M. Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. Br J Clin Pharmacol 2001;51:81-6.
13. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Safety 2000;23:165-72.
14. Castel JM, Figueras A, Pedros C, Laporte JR, Capella D. Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription pads. Drug Safety 2003;26:1049-55.
15. Ferguson M, Dhillon S. A survey of adverse drug reaction reporting by hospital pharmacists to the Committee on Safety of Medicines - the role of pharmacy departments. Int J Pharm Pract 1999;7:167-71.
16. Green CF, Mottram DR, Rowe PH, Brown AM. Adverse drug reaction monitoring by United Kingdom hospital pharmacy departments: impact of the introduction of "yellow card" reporting for pharmacists. Int J Pharm Pract 1999;7:238-46.
17. Cox A. What can hospital pharmacy do to increase adverse drug reaction reporting? Pharm Pract 2001;11:84.
18. Yap K. Adverse drug reactions monitoring systems used by Australian hospitals. Aust J Hosp Pharm 1982;12:2-7.
19. Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Clinical Pharmacy. SHPA Standards of Practice for Clinical Pharmacy. SHPA Practice Standards 1996;2.5-2.6.
20. Portney LG, Watkins MP. Foundations of clinical research: Applications to practice. New Jersey: Prentice Hall; 2000.
21. Colodny L, Spillane J. Toward increased reporting of adverse drug reactions. Hosp Pharm 1999;34:1179-85.
22. Feely J, Moriarty S, O'Connor P. Stimulating reporting of adverse drug reactions by using a fee. BMJ 1990;300:22-3.
23. Elkerton JR. The documentation of adverse drug reactions. Aust J Hosp Pharm 1995;25:502-7.
24. Thurmann PA. Methods and systems to detect adverse drug reactions in hospitals. Drug Safety 2001;24:961-8.
25. Smith CC, Bennett PM, Pearce HM, Harrison PI, Reynolds DJ, Aronson JK, et al. Adverse drug reactions in a hospital general medical unit meriting notification to the Committee on Safety of Medicines. Br J Clin Pharmacol 1996;42:423-9.
26. Suveges LG, Gesy KF, Wallace SM, Blackburn JL, Appel WC. Adverse drug reaction reporting part II: evaluation of the Saskatchewan pilot project for a regional reporting program in Canada. Drug Inf J 1995;29:581-9.
27. Scott HD, Thacher-Renshaw A, Rosenbaum SE, Waters WJ, Green M, Andrews LG, et al. Physician reporting of adverse drug reactions: results of the Rhode Island adverse drug reaction reporting project. JAMA 1990;263:1785-8.
28. Raymond PM, Robertson MB. Adverse drug reaction reporting in Melbourne teaching hospitals. Aust J Hosp Pharm 1994;24:237-42.